|
End-of-day quote
Shanghai S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 8.110 CNY | +1.37% |
|
+0.87% | -35.43% |
| 21/08 | KPC Pharmaceuticals,Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 27/07 | KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs | MT |
| Market Cap | 613.91Cr 92Cr 81Cr 76Cr 69Cr 130.52Cr 8.8TCr 131.74Cr 918.88Cr 356.07Cr 4.5TCr 343.77Cr 336.31Cr 14TCr | P/E 2026 * |
38x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 613.91Cr 92Cr 81Cr 76Cr 69Cr 130.52Cr 8.8TCr 131.74Cr 918.88Cr 356.07Cr 4.5TCr 343.77Cr 336.31Cr 14TCr | EV / Sales 2026 * |
1.08x | EV / Sales 2027 * | 0.98x |
| Free-Float |
61.63% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.37% | ||
| 1 week | +0.87% | ||
| 1 month | -4.02% | ||
| 3 months | -1.93% | ||
| 6 months | -29.23% | ||
| Current year | -35.43% |
| 1 week | 7.97 |  | 8.15 |
| 1 month | 7.97 | | 8.66 |
| Current year | 7.45 | | 13.55 |
| 1 year | 7.45 | | 14.46 |
| 3 years | 7.45 | | 24.11 |
| 5 years | 7.45 | | 26.09 |
| 10 years | 5.95 | | 26.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Sun
DFI | Director of Finance/CFO | - | 03/01/2023 |
Jiang Zhong
PSD | President | 51 | 05/01/2026 |
Yu Dong
IRC | Investor Relations Contact | 37 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Li Meng
BRD | Director/Board Member | - | - |
Jin Guo Xin
BRD | Director/Board Member | 64 | 01/11/2009 |
Zhi Yang
BRD | Director/Board Member | 66 | 08/12/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.37% | +0.87% | -41.91% | -57.74% | 92Cr | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,01900Cr | |
| -1.02% | -5.60% | +35.72% | +64.82% | 62TCr | |
| +1.11% | -0.58% | +12.36% | +78.27% | 46TCr | |
| +0.34% | -3.01% | +61.79% | +41.79% | 36TCr | |
| -0.95% | -4.05% | +20.54% | +40.33% | 33TCr | |
| -1.46% | -2.89% | +10.57% | +26.54% | 27TCr | |
| -1.35% | -5.43% | -6.17% | +8.82% | 24TCr | |
| -1.04% | -2.79% | +35.30% | +54.42% | 22TCr | |
| -1.87% | -4.10% | +28.44% | +97.54% | 18TCr | |
| Average | -0.55% | -3.09% | +19.27% | +47.24% | 36.98TCr | |
| Weighted average by Cap. | -0.60% | -3.32% | +29.06% | +71.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 565.97Cr 84Cr 75Cr 70Cr 64Cr 120.33Cr 8.11TCr 121.45Cr 847.13Cr 328.26Cr 4.15TCr 316.93Cr 310.05Cr 13TCr | 627.4Cr 94Cr 83Cr 78Cr 71Cr 133.39Cr 9TCr 134.64Cr 939.08Cr 363.89Cr 4.6TCr 351.33Cr 343.7Cr 15TCr |
| Net income | 16Cr 2.44Cr 2.17Cr 2.02Cr 1.84Cr 3.48Cr 234.57Cr 3.51Cr 24Cr 9.49Cr 119.91Cr 9.16Cr 8.96Cr 384.85Cr | 34Cr 5.01Cr 4.45Cr 4.15Cr 3.79Cr 7.14Cr 481.46Cr 7.21Cr 50Cr 19Cr 246.13Cr 19Cr 18Cr 789.92Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | CN¥8.110 | +1.37% | 43,25,588 |
| 29/26/29 | CN¥8.000 | -0.37% | 26,93,100 |
| 28/26/28 | CN¥8.030 | -0.12% | 33,84,492 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600422 Stock
Select your edition
All financial news and data tailored to specific country editions
